Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (126) 126
index medicus (108) 108
male (96) 96
female (88) 88
adult (78) 78
infectious diseases (66) 66
middle aged (63) 63
hiv (62) 62
hiv infections - drug therapy (54) 54
immunology (44) 44
antiretroviral therapy (39) 39
risk factors (39) 39
pediatrics (31) 31
cd4 lymphocyte count (30) 30
aids (27) 27
cohort studies (26) 26
mortality (25) 25
hiv infections - complications (23) 23
human immunodeficiency virus--hiv (23) 23
prospective studies (23) 23
treatment outcome (23) 23
aged (22) 22
antiviral agents (22) 22
health aspects (22) 22
life sciences (22) 22
medicine (22) 22
anti-hiv agents - therapeutic use (21) 21
infants (21) 21
microbiology (21) 21
netherlands (21) 21
viral load (21) 21
virology (21) 21
aids/hiv (20) 20
infant, newborn (20) 20
adolescent (19) 19
anti-hiv agents - adverse effects (18) 18
hiv infections - immunology (17) 17
research article (17) 17
resuscitation (17) 17
young adult (17) 17
abridged index medicus (16) 16
care and treatment (16) 16
drug therapy (16) 16
highly active antiretroviral therapy (16) 16
hiv infections - virology (16) 16
myocardial-infarction (16) 16
research (16) 16
cohort (15) 15
hiv infection (15) 15
hiv-1 (15) 15
human-immunodeficiency-virus (15) 15
individuals (15) 15
animals (14) 14
antiretroviral drugs (14) 14
acquired immune deficiency syndrome (13) 13
acquired immune deficiency syndrome--aids (13) 13
analysis (13) 13
antiretroviral therapy, highly active (13) 13
article (13) 13
cardiovascular disease (13) 13
disease progression (13) 13
infection (13) 13
multidisciplinary sciences (13) 13
science (13) 13
therapy (13) 13
ventilation (13) 13
active antiretroviral therapy (12) 12
anti-retroviral agents - therapeutic use (12) 12
birth (12) 12
cardiovascular diseases (12) 12
drug therapy, combination (12) 12
incidence (12) 12
infected patients (12) 12
medicine & public health (12) 12
medicine, general & internal (12) 12
retrospective studies (12) 12
antiretroviral agents (11) 11
babies (11) 11
europe (11) 11
hiv infections - mortality (11) 11
hiv-1-infected patients (11) 11
infections (11) 11
medical research (11) 11
netherlands - epidemiology (11) 11
protease inhibitors (11) 11
time factors (11) 11
antiretroviral therapy, highly active - methods (10) 10
comparative analysis (10) 10
hiv infections - epidemiology (10) 10
hiv patients (10) 10
hiv-infected patients (10) 10
lamivudine (10) 10
patients (10) 10
physiology (10) 10
usage (10) 10
ventilators (10) 10
age (9) 9
age factors (9) 9
aged, 80 and over (9) 9
association (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text High treatment uptake in human immunodeficiency virus/ hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands
by Boerekamps, A and Newsum, Astrid M and Smit, C and Arends, Joop and Richter, C and Reiss, Peter and Rijnders, Bart and Brinkman, K and Valk, Marc and Geerlings, Suzanne and Godfried, M.H and Goorhuis, Abraham and Hovius, Joppe and Meer, J. T M and Kuijpers, Taco W and Nellen, F. J B and Van Der Poll, D.T and Prins, Jan and Van Vugt, H.J.M and Wiersinga, W.J and Wit, Ferdinand and Van Duinen, M and Van Eden, J and Van Hes, A.M.H and Mutschelknauss, M and Nobel, H.E and Pijnappel, F.J.J and Weijsenfeld, A.M and Jurriaans, Suzanne and Back, Nicole and Zaaijer, Hans and Berkhout, Ben and Cornelissen, Marion and Schinkel, C.J and Wolthers, Katja and Van Den Berge, M and Stegeman, A and Baas, S and Hage De Looff, L and Wintermans, B and Veenemans, J and Pronk, Marjolijn and Ammerlaan, Heidi and De Munnik, E.S and Jansz, A.R and Tjhie, J and Wegdam, M.C.A and Deiman, B and Scharnhorst, V and Eeden, Arne and Brokking, W and Groot, Marieke and Elsenburg, L.J.M and Damen, M and Kwa, I.S and Kasteren, Marjo and Brouwer, A.E and Van Erve, R and De Kruijf-Van De Wiel, B.A.F.M and Keelan-Pfaf, S and Van Der Ven, B and Van Der Ven, B and Buiting, Anton and Kabel, P.J and Versteeg, D and Ende, Marchina and Bax, Hannelore and Gorp, Eric and Nouwen, Jan and Schurink, Carolina and Verbon, Annelies and Vriessluijs, Theodora and De Jong-Peltenburg, N.C and Bassant, N and Van Beek, J.E.A and Vriesde, M and van Zonneveld, Laura and Van Den Berg-Cameron, H.J and Groot, Jan Cees and De Zeeuw-De Man, M and Boucher, Charles and Koopmans, Marion and Kampen, Jeroen and Pas, Suzan and Branger, J and Rijkeboer-Mes, A and Duijf-Van De Ven, C.J.H.M and Schippers, E.F and Nieuwkoop, Cees and Van IJperen, J.M and Geilings, J and Van Der Hut, G and Burgel, Nathalie and Leyten, Eliane and Gelinck, Luc and Van Hartingsveld, A.Y and Meerkerk, C and Wildenbeest, G.S and Heikens, E and Groeneveld, P.H.P and ... and Netherlands ATHENA HIV Observation and NVHB-SHM Hepatitis Working Grp and NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort
Clinical Infectious Diseases, ISSN 1058-4838, 05/2018, Volume 66, Issue 9, pp. 1352 - 1359
markdownabstractBackground The Netherlands has provided unrestricted access to direct-acting antivirals (DAAs) since November 2015. We analyzed the nationwide... 
Treatment uptake | HIV/HCV coinfection | Direct-acting antivirals | treatment uptake | INFECTIOUS DISEASES | EFFICACY | SAFETY | SEX | MICROBIOLOGY | IMMUNOLOGY | direct-acting antivirals | INDIVIDUALS | HIV | REINFECTION | MEN | INFECTION | COHORT | AMSTERDAM
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss
by van Vonderen, Marit G. A and van Agtmael, Michiel A and Hassink, Elly A. M and Milinkovic, Ana and Brinkman, Kees and Geerlings, Suzanne E and Ristola, Matti and van Eeden, Arne and Danner, Sven A and Reiss, Peter and Mediclas Study Grp and MEDICLAS study group and for the MEDICLAS study group
PLoS ONE, ISSN 1932-6203, 2009, Volume 4, Issue 5, pp. e5647 - e5647
Background: Lipoatrophy is known to be associated with stavudine as part of the treatment for HIV infection, but it is less clear if this serious side effect... 
MULTIDISCIPLINARY SCIENCES | Anti-HIV Agents - pharmacology | Humans | Middle Aged | Male | Lamivudine - adverse effects | Lipodystrophy - virology | Body Composition - drug effects | Lipids - blood | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Anti-HIV Agents - blood | Biomarkers - metabolism | HIV Infections - blood | Zidovudine - adverse effects | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Lopinavir | Lamivudine - blood | Zidovudine - pharmacology | Lipodystrophy - complications | Pyrimidinones - blood | Adolescent | HIV Infections - complications | Glucose - metabolism | HIV Infections - drug therapy | Lipodystrophy - chemically induced | Zidovudine - therapeutic use | Aged | Lamivudine - pharmacology | Zidovudine - blood | Highly active antiretroviral therapy | CT imaging | Care and treatment | AIDS treatment | Physiological aspects | DNA polymerases | Stavudine | HIV (Viruses) | Health aspects | HIV infection | Zidovudine | Therapy | RNA-directed DNA polymerase | Nevirapine | Body fat | Ritonavir | Cardiovascular disease | Standard error | Infections | Density | Body composition | Randomization | Computed tomography | Acquired immune deficiency syndrome--AIDS | Body composition (biology) | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Antiretroviral drugs | Dual energy X-ray absorptiometry | Lamivudine | Cholesterol | Antiretroviral therapy | Side effects | Protease inhibitors | Lipoatrophy | Lipodystrophy | Index Medicus | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial
by Grijsen, Marlous L and Steingrover, Radjin and Wit, Ferdinand W. N. M and Jurriaans, Suzanne and Verbon, Annelies and Brinkman, Kees and van der Ende, Marchina E and Soetekouw, Robin and de Wolf, Frank and Lange, Joep M. A and Schuitemaker, Hanneke and Prins, Jan M and Vermeulen, J. N and Nievaard, M and Slegtenhorst, B and Doevelaar, H and Koevoets, W and Nobel, H. E and Henderiks, A and Pijnappel, F. J. J and van der Ende, M. E and Rijinders, B. J. A and Padmos, I and van Zonneveld, L and Been, S and Kauffmann, R. H and Schippers, E. F and Korte, R and van Ijperen, J. M and ten Kate, R. W and Soetekouw, R and Hulshoff, N and Schoemaker-Ransijn, M and Kroon, F. P and Dorama, W and Moons, C. A. M and Verbon, A and Lowe, S. H and Schreij, G and van der Geest, S and Oude Lashof, A. M and Schippers, J and Bronsveld, W and van Twillert, G and van Houte, D and van Vonderen, M. G. A and Faber, S and Rotteveel, S and ten Napel, C. H. H and Kootstra, G. J and Primo-SHM Study Grp and Primo-SHM Study Group and on behalf of the Primo-SHM Study Group
PLoS medicine, ISSN 1549-1277, 2012, Volume 9, Issue 3, p. e1001196
Background: The objective of this study was to assess the benefit of temporary combination antiretroviral therapy (cART) during primary HIV infection (PHI).... 
INDIVIDUALS | PLASMA VIREMIA | MEDICINE, GENERAL & INTERNAL | OBSERVATIONAL COHORT | THERAPY | IMMUNODEFICIENCY-VIRUS TYPE-1 | VIROLOGICAL SET-POINT | CELL DECLINE | DRUG-RESISTANCE | IMMUNE FUNCTION | INTERRUPTION | Anti-Retroviral Agents - therapeutic use | Drug Administration Schedule | HIV Infections - virology | Humans | Middle Aged | Adult | Female | HIV Infections - drug therapy | Male | Viral Load | Physiological aspects | Antiviral agents | Care and treatment | HIV (Viruses) | Comparative analysis | Health aspects | Medical research | Acquired immune deficiency syndrome--AIDS | Drug therapy | Human immunodeficiency virus--HIV | AIDS | Human immunodeficiency virus | HIV | Acquired immune deficiency syndrome
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM
by Newsum, Astrid M and Kooij, Katherine W and Boyd, Anders and Smit, Colette and Wit, Ferdinand W. N. M and van der Meer, Jan T. M and Prins, Maria and Reiss, Peter and van der Valk, Marc and van Eden, H and Molenkamp, R and Pijnappel, F. J. J and Reesink, H. W and Schinkel, J and Steba, G. S and van den Berk, G. E. L and Brinkman, K and Hooijenga, I and Kwa, D and van der Meche, N and Toonen, A. J. M and Vos, D and van Broekhuizen, M. C and Lauw, E. N and Mulder, J. W and Arend, J. E and van Kessel, A and Silvius, B and Versloot, M and Boonstra, A and Rijnders, B. J. A and Brokking, W and van Eeden, A and Elsenburg, L and Nobel, H. E and van de Laar, T. J. W and van der Veldt, W and Geerlings, S. E and Goorhuis, A and Hovius, J. W and Lempkes, B and Nellen, F. J. B and van der Poll, T and Prins, J. M and van Vugt, M and Wiersinga, W. J and van Duinen, M and van Eden, J and Hazenberg, A and van Hes, A. M. H and Smalhout, S. Y and Weijsenfeld, A. M and Jurriaans, S and Back, N. K. T and Zaaijer, H. L and Berkhout, B and Cornelissen, M. T. E and Schinkel, C. J and Wolthers, K. C and Peters, E. J. G and van Agtmael, M. A and Bomers, M and Sigaloff, K. C. E and Heitmuller, M and Laan, L. M and Ang, C. W and van Houdt, R and Jonges, M and Pettersson, A. M and van Prehn, J and van den Berge, M and Stegeman, A and Baas, S and de Looff, L. Hage and Wintermans, B and Veenemans, J and Pronk, M. J. H and Ammerloan, H. S. M and de Munnik, E. S and Jansz, A. R and Tjhie, J and Wegdam, M. C. A and Deiman, B and Scharnhorst, V and Elsenburg, L. J. M and Nobel, H and Damen, M and van Kasteren, M. E. E and Berrevoets, M. A. H and Brouwer, A. E and Adams, A and de Kruijf-van de Wiel, B. A. Em and Keelan-Pfaf, S and van der Ven, B and Buiting, A. G. M and Murck, J. L and Versteeg, D and van der Ende, M. E and Box, H., I and van Gorp, E. C. M and ...
AIDS, ISSN 0269-9370, 04/2019, Volume 33, Issue 5, pp. 833 - 844
liver fibrosis | fibrosis-4 | HIV/hepatitis C virus coinfection | MSM | acute hepatitis C virus infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV
by van Zoest, Rosan A and Law, Matthew and Sabin, Caroline A and Vaartjes, Ilonca and Van der Valk, Marc and Arends, Joop E and Reiss, Peter and Wit, F. W. M. N and Geerlings, S. E and Godfried, M. H and Goorhuis, A and Hovius, J. W and Kuijpers, T. W and Nellen, F. J. B and van der Poll, D. T and Prins, J. M and van Vugt, H. J. M and Wiersinga, W. J and van Duinen, M and van Eden, J and van Hes, A. M. H and Pijnappel, F. J. J and Weijsenfeld, A. M and Jurriaans, S and Back, N. K. T and Zaaijer, H. L and Berkhout, B and Cornelissen, M. T. E and Schinkel, C. J and Wolthers, K. C and Peters, E. J. G and van Agtmael, M. A and Bomers, M and Heitmuller, M and Laan, L. M and Ang, C. W and van Houdt, R and Pettersson, A. M and Vandenbroucke-Grauls, C. M. J. E and van den Berge, M and Stegeman, A and Baas, S and de Looff, L. Hage and Wintermans, B and Veenemans, J and Pronk, M. J. H and Ammerlaan, H. S. M and de Munnik, E. S and Jansz, A. R and Tjhie, J and Wegdam, M. C. A and Deiman, B and Scharnhorst, V and van Eeden, A and Brokking, W and Groot, M and Elsenburg, L. J. M and Damen, M and Kwa, I. S and van Kasteren, M. E. E and Brouwer, A. E and van Erve, R and de Kruijf-van de Wiel, B. A. F. M and van de Ven, B and Buiting, A. G. M and Kabel, P. J and Versteeg, D and van der Ende, M. E and Bax, H. I and van Gorp, E. C. M and Nouwen, J. L and Rijnders, B. J. A and Schurink, C. A. M and Verbon, A and de Vries-Sluijs, T. E. M. S and de Jong-Peltenburg, N. C and Bassant, N and van Beek, J. E. A and Vriesde, M and van Zonneveld, L. M and van den Berg-Cameron, H. J and de Groot, J and de Zeeuw-de Man, M and Boucher, C. A. B and Koopmans, M. P. G and van Kampen, J. J. A and Pas, S. D and Branger, J and Douma, R. A and Duijf-van de Ven, C. J. H. M and Schippers, E. F and van Nieuwkoop, C and van IJperen, J. M and Geilings, J and van der Hut, G and van Burgel, N. D and Leyten, E. M. S and Gelinck, L. B. S and Davids-Veldhuis, S and van Hartingsveld, A. Y and ...
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 08/2019, Volume 81, Issue 5, pp. 562 - 571
cardiovascular disease | risk prediction algorithms | HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect
by Smolders, E. J and Smit, C and de Kanter, C. T. M. M and Dofferhoff, A. S. M and Arends, J. E and Brinkman, K and Rijnders, B and van der Valk, M and Reiss, P and Burger, D. M and Prins, J. M and Kuijpers, T. W and Scherpbier, H. J and van der Meer, J. T. M and Wit, F. W. M. N and Godfried, M. H and van der Poll, T and Nellen, F. J. B and Geerlings, S. E and van Vugt, M and Pajkrt, D and Wiersinga, W. J and Goorhuis, A and Hovius, J. W and Bijsterveld, M. A. H and van Eden, J and van Hes, A. M. H and Mutschelknauss, M and Nobel, H. E and Pijnappel, F. J. J and Weijsenfeld, A. M and Jurriaans, S and Back, N. K. T and Zaaijer, H. L and Berkhout, B and Cornelissen, M. T. E and Schinkel, C. J and Thomas, X. V and van den Berge, M and Stegeman, A and Baas, S and Hage de Looff, L and Wintermans, B and Veenemans, J and Pronk, M. J. H and Ammerlaan, H. S. M and de Munnik, E. S and Langebeek, N and van Wijk, M and Vandenbroucke-Grauls, C. M. J. E and ATHENA Natl HIV Observational and ATHENA National HIV Observational Cohort and the ATHENA National HIV Observational Cohort
HIV medicine, ISSN 1464-2662, 2018, Volume 19, Issue 3, pp. 216 - 226
Direct-acting antivirals (DAAs) for treatment of chronic hepatitis C virus (HCV) infection can cause drug-drug interactions (DDIs) with combination... 
co‐medication | direct‐acting antivirals | HIV | combination antiretroviral therapy | hepatitis C | drug–drug interactions | co-medication | direct-acting antivirals | INFECTIOUS DISEASES | drug-drug interactions | THERAPY | SOFOSBUVIR | INFECTION | Hepacivirus - drug effects | Antiviral Agents - pharmacology | Prospective Studies | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Coinfection - drug therapy | Humans | Middle Aged | Male | Practice Patterns, Physicians | Netherlands | Drug Interactions | Observational Studies as Topic | Female | HIV Infections - drug therapy | Retrospective Studies | Sustained Virologic Response | Hepatitis | Complications and side effects | Highly active antiretroviral therapy | Squamous cell carcinoma | Protease inhibitors | Comorbidity | Proteases | Drug interactions | Digital integrated circuits | Hepatitis C virus | Medical personnel | Drugs | Therapy | Physicians | Chronic infection | Viruses | Patients | Antiretroviral therapy | Antiretroviral agents | Human immunodeficiency virus--HIV | Hepatitis C
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort
by Rokx, C and Gras, L and van de Vijver, Damc and Verbon, A and Rijnders, Bja and Prins, J. M and Kuijpers, T. W and Scherpbier, H. J and van der Meer, J. T. M and Wit, F. W. M. N and Godfried, M. H and Reiss, P and van der Poll, T and Nellen, F. J. B and Lange, J. M. A and Geerlings, S. E and van Vugt, M and Pajkrt, D and Bos, J. C and van der Valk, M and Wiersinga, W. J and Goorhuis, A and Hovius, J. W. R and Lowe, S and Oude Lashof, A and Posthouwer, D and Pronk, M. J. H and Ammerlaan, H. S. M and van der Ende, M. E and de Vries-Sluijs, T. E. M. S and Schurink, C. A. M and Nouwen, J. L and van Gorp, E. C. M and van der Feltz, M and essen, G. J. A and van Rossum, A. M. C and Branger, J and Schippers, E. F and van Nieuwkoop, C and van Elzakker, E. P and Groeneveld, P. H. P and Bouwhuis, J. W and Soetekouw, R and ten Kate, R. W and Kroon, F. P and van Dissel, J. T and Arend, S. M and de Boer, M. G. J and Jolink, H and Vollaard, A. M and ATHENA Natl Observational Cohort and ATHENA National Observational Cohort Study and the ATHENA National Observational Cohort Study
HIV medicine, ISSN 1464-2662, 2016, Volume 17, Issue 8, pp. 571 - 580
Lamivudine (3TC) and emtricitabine (FTC) are considered interchangeable in recommended tenofovir disoproxil-fumarate (TDF)-containing combination... 
emtricitabine | HIV‐1 | boosted protease inhibitors | antiretroviral therapy | lamivudine | Emtricitabine | HIV-1 | Lamivudine | Antiretroviral therapy | Boosted protease inhibitors | ANTIRETROVIRAL-NAIVE | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | ONCE-DAILY DOLUTEGRAVIR | SUPPRESSED PATIENTS | REVERSE-TRANSCRIPTASE | INITIAL TREATMENT | RESISTANCE PROFILES | MULTICENTER TRIAL | CONTAINING REGIMENS | HIV-1 INFECTION | Emtricitabine - therapeutic use | Humans | Middle Aged | Male | Viral Load | Young Adult | Netherlands | HIV-1 - isolation & purification | Treatment Failure | Adolescent | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Antiretroviral Therapy, Highly Active - methods | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome
by Worm, Signe W and Friis-Møller, Nina and Bruyand, Mathias and D'Arminio Monforte, Antonella and Rickenbach, Martin and Reiss, Peter and El-Sa, Wafaa and Phillips, Anew and Lundgren, Jens and Sabin, Caroline and de Wolf, F and Zaheri, S and Gras, L and Bronsveld, W and Hillebrand-Haverkort, M. E and Prins, J. M and Bos, J. C and Eeftinck Schattenkerk, J. K. M and Geerlings, S. E and Godfried, M. H and Lange, J. M. A and van Leth, F. C and Lowe, S. H and van der Meer, J. T. M and Nellen, F. J. B and Pogány, K and van der Poll, T and Ruys, Th A and Steingrover, R and van Twillert, G and van der Valk, M and van Vonderen, M. G. A and Vrouenraets, S. M. E and van Vugt, M and Wit, F. W. M. N and van Eeden, A and ten Veen, J. H and van Dam, P. S and Roos, J. C and Brinkman, K and Frissen, P. H. J and Weigel, H. M and Mulder, J. W and van Gorp, E. C. M and Meenhorst, P. L and Mairuhu, A. T. A and Veenstra, J and Danner, S. A and van Agtmael, M. A and Claessen, F. A. P and DAD Study Grp and D:A:D study group
AIDS (London, England), ISSN 0269-9370, 2010, Volume 24, Issue 3, pp. 427 - 435
INTRODUCTION: This study describes the characteristics of the metabolic syndrome in HIV-positive patients in the Data Collection on Adverse Events of Anti-HIV... 
Observational study | HIV | Metabolic syndrome | Epidemiology | STATEMENT | INFECTIOUS DISEASES | MANAGEMENT | GUIDELINES | COMPONENTS | ADULTS | IMMUNOLOGY | SOCIETY | observational study | metabolic syndrome | epidemiology | VIROLOGY | CARDIOVASCULAR-DISEASE | LIPID PROFILES | COMBINATION ANTIRETROVIRAL THERAPY | ASSOCIATION | HIV-1 | United States - epidemiology | Prevalence | Prospective Studies | HIV Infections - epidemiology | Humans | Middle Aged | Male | CD4 Lymphocyte Count | Antihypertensive Agents - therapeutic use | Metabolic Syndrome - drug therapy | Metabolic Syndrome - diagnosis | HIV Infections - complications | Adult | Female | Hypolipidemic Agents - therapeutic use | Metabolic Syndrome - epidemiology | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Temporary antiretroviral treatment during primary HIV-1 infection has a positive impact on health-related quality of life: data from the Primo-SHM cohort study
by Grijsen, M. L and Koster, G. T and van Vonderen, M. G. A and van Kasteren, M and Kootstra, G. J and Steingrover, R and de Wolf, F and Prins, J. M and Nieuwkerk, P. T and Lange, J. M. A and Vermeulen, J. N and Nievaard, M and Slegtenhorst, B and Doevelaar, H and Koevoets, W and Nobel, H. E and Hendericks, A and Pijnappel, F. J. J and van der Ende, M. E and Rijnders, B. J. A and Padmos, I and van Zonneveld, L and Been, S and Kauffmann, R. H and Schippers, E. F and Korte, R and van Ijperen, J. M and Kate, R. W and Soetekouw, R and Hulshoff, N and Schoemaker-Ransijn, M and Kroon, F. P and Dorama, W and Moons, C. A. M and Verbon, A and Lowe, S. H and Schreij, G and van der Geest, S and Oude Lashof, A. M and Schippers, J and Bronsveld, W and van Twillert, G and van Houte, D and Faber, S and Rotteveel, S and ten Napel, C. H. H and Heins, H and Brinkman, K and van den Berk, G. E. L and Blok, W. L and Primo-SHM Study Grp and Primo-SHM study group
HIV medicine, ISSN 1464-2662, 2012, Volume 13, Issue 10, pp. 630 - 635
The aim of the study was to compare health-related quality of life (HRQL) over 96 weeks in patients receiving no treatment or 24 or 60 weeks of combination... 
acute HIV infection | health‐related quality of life | primary HIV infection | combination antiretroviral therapy | Health-related quality of life | Primary HIV infection | Acute HIV infection | Combination antiretroviral therapy | TRIAL | INFECTIOUS DISEASES | THERAPY | health-related quality of life | MEDICAL OUTCOMES | Prospective Studies | Drug Administration Schedule | HIV-1 - drug effects | Humans | Middle Aged | HIV Seropositivity - drug therapy | Linear Models | Male | Disease Progression | Viral Load | Young Adult | Time Factors | Adolescent | Quality of Life | Adult | Anti-HIV Agents - therapeutic use | Female | Surveys and Questionnaires | Health Status | Cohort Studies | Highly active antiretroviral therapy | Antiviral agents | Analysis | Gastrointestinal diseases | Drug therapy | HIV (Viruses) | Health aspects | HIV infection | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Increased Virological Failure in Naive HIV-1-Infected Patients Taking Lamivudine Compared With Emtricitabine in Combination With Tenofovir and Efavirenz or Nevirapine in the Dutch Nationwide ATHENA Cohort
by Rokx, Casper and Fibriani, Azzania and van de Vijver, David A. M. C and Verbon, Annelies and Schutten, Martin and Gras, Luuk and Rijnders, Bart J. A and Prins, J. M and Kuijpers, T. W and Scherpbier, H. J and van der Meer, J. T. M and Wit, F. W. M. N and Godfried, M. H and Reiss, P and van der Poll, T and Nellen, F. J. B and Lange, J. M. A and Geerlings, S. E and van Vugt, M and Pajkrt, D and Bos, J. C and van der Valk, M and Wiersinga, W. J and Goorhuis, A and Hovius, J. W. R and Lowe, S and Oude Lashof, A and Posthouwer, D and Pronk, J. H and Ammerlaan, H. S. M and van der Ende, M. E and de Vries-Sluijs, T. E. M. S and Schurink, C. A. M and Nouwen, J. L and Verbon, A and Rijnders, B. J. A and van Gorp, E. C. M and van der Feltz, M and essen, G. J. A and van Rossum, A. M. C and Branger, J and Schippers, E. F and van Nieuwkoop, C and van Elzakker, E. P and Groeneveld, P. H. P and Bouwhuis, J. W and Soetekouw, R and ten Kate, R. W and Kroon, F. P and van Dissel, J. T and AIDS Therapy Evaluation and AIDS Therapy Evaluation in the Netherlands National Observational Cohort and for the AIDS Therapy Evaluation in the Netherlands (ATHENA) National Observational Cohort
Clinical infectious diseases, ISSN 1058-4838, 2015, Volume 60, Issue 1, pp. 143 - 153
Background. Guidelines for treatment of human immunodeficiency virus type 1 (HIV-1) infection consider lamivudine and emtricitabine to be interchangeable... 
HIV-1 | emtricitabine | virological failure | antiretroviral therapy | lamivudine | INFECTIOUS DISEASES | EFFICACY | ZIDOVUDINE/LAMIVUDINE | MICROBIOLOGY | RESISTANCE PROFILES | IMMUNOLOGY | DISOPROXIL FUMARATE | CONTAINING REGIMENS | Anti-Retroviral Agents - therapeutic use | HIV Infections - epidemiology | HIV Infections - virology | Humans | Middle Aged | Netherlands - epidemiology | Male | Viral Load | Incidence | HIV-1 - isolation & purification | Treatment Failure | Adult | Female | HIV Infections - drug therapy | Antiretroviral Therapy, Highly Active - methods | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights